Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
11/13/2002 | CN1379068A Low foaming N-alkyl-tartraimine and N-alkyl melicimine wetting agent |
11/13/2002 | CN1094126C Pyrroloazepine compounds |
11/12/2002 | US6479668 Method of producing pyrrolidine derivatives |
11/12/2002 | US6479667 Crystalline forms of antibiotic side chain intermediates |
11/12/2002 | US6479587 Crosslinkable polyurea polymers |
11/12/2002 | US6479554 Immunotherapeutic agents |
11/12/2002 | US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity |
11/12/2002 | US6479550 α-sulfenimino acid derivatives |
11/12/2002 | US6479531 Gastrin and cholecystokinin receptor ligands |
11/12/2002 | US6479524 To prolong the thrombin time |
11/12/2002 | US6479518 Zwitterionic tachykinin receptor antagonists |
11/12/2002 | US6479502 Hydroxamic acid derivatives as proteinase inhibitors |
11/12/2002 | US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies |
11/12/2002 | CA2144294C (pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments |
11/12/2002 | CA2034983C Dispersant compositions |
11/07/2002 | WO2002088298A1 Compounds, compositions, and methods for controlling biofilms |
11/07/2002 | WO2002088094A1 2-iminoimidazole derivatives (1) |
11/07/2002 | WO2002088092A1 2-iminoimidazole derivative (2) |
11/07/2002 | WO2002088082A2 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
11/07/2002 | WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
11/07/2002 | WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors |
11/07/2002 | WO2002087759A1 Polymer-bound catalyst for the enantioselective aldol or mannich reaction |
11/07/2002 | WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
11/07/2002 | US20020165398 Amino-thiophene-amido derivatives |
11/07/2002 | US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
11/07/2002 | US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
11/07/2002 | US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders |
11/07/2002 | US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives |
11/07/2002 | CA2445874A1 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
11/07/2002 | CA2445591A1 Nitrogen heterocyclic compounds and compositions for controlling biofilms |
11/06/2002 | EP1254907A1 Pyrrolopyridazine compound |
11/06/2002 | EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
11/06/2002 | EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
11/06/2002 | EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
11/06/2002 | EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
11/06/2002 | EP1253922A2 Statin-type bone growth stimulators |
11/06/2002 | EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
11/06/2002 | CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain |
11/06/2002 | CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists |
11/06/2002 | CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors |
11/06/2002 | CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
11/06/2002 | CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
11/06/2002 | CN1377647A 4-mercaptopyrrolidinyl derivative as fernesyl transferase inhibitor |
11/06/2002 | CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
11/06/2002 | CN1093853C New method for preparing (S)-4-amino-hepta-5,6-dienoic acid and intermediate thereof |
11/06/2002 | CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine |
11/05/2002 | US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
11/05/2002 | US6476235 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
11/05/2002 | US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity |
11/05/2002 | US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
11/05/2002 | US6476062 Chemokine receptor antagonists |
11/05/2002 | US6476061 Fungicides containing pyrrolidones as their active agents |
11/05/2002 | US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
11/05/2002 | US6476053 Mycobacterial inhibitors |
11/05/2002 | US6476027 N-hydroxy 4-sulfonyl butanamide compounds |
11/05/2002 | US6476026 Compounds and compositions as protease inhibitors |
11/05/2002 | US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents |
11/05/2002 | CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
11/05/2002 | CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments |
10/31/2002 | WO2002085925A2 Melanocortin receptor ligands |
10/31/2002 | WO2002085855A1 2-iminopyrrolidine derivatives |
10/31/2002 | WO2002085853A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
10/31/2002 | WO2002085852A1 Pyrrole compound and agricultural or horticultural bactericide |
10/31/2002 | WO2002085851A1 Pyrrole derivative |
10/31/2002 | WO2002085850A1 Cyclic amidine derivative |
10/31/2002 | WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
10/31/2002 | WO2002085350A1 Prodigiosin composition for the treatment of rheumatic arthritis |
10/31/2002 | WO2001058855A9 Use of androgen receptor suppressors |
10/31/2002 | US20020161252 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine)) |
10/31/2002 | US20020161241 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
10/31/2002 | US20020161240 Synthetic multimerizing agents |
10/31/2002 | US20020161239 Process for producing crystalline atorvastatin calcium |
10/31/2002 | US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain |
10/31/2002 | US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition |
10/31/2002 | US20020161021 Beta hydroxy ketone treated with trialkylborane or dialkylalkoxyborane followed by recovery and reuse of alkylborane |
10/31/2002 | US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
10/31/2002 | US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient |
10/31/2002 | CA2444599A1 Melanocortin receptor ligands |
10/31/2002 | CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
10/30/2002 | WO2001083444A1 Method for producing cyclic lactams |
10/30/2002 | EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
10/30/2002 | EP1252141A1 Tosylproline analogs as thymidylate synthase inhibitors |
10/30/2002 | EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
10/30/2002 | EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
10/30/2002 | EP1251822A1 Novel coupler for use in oxidative hair dyeing |
10/30/2002 | CN1377376A Recovery of modifier compounds and polar organic compounds from a poly (arylene sulfide) |
10/30/2002 | CN1377350A Process for production of naphthyridine-3-carboxylic acid derivatives |
10/30/2002 | CN1377341A Amycomycin, production thereof and its use as pharmaceutical |
10/30/2002 | CN1377268A Cell adhesion inhibitors |
10/30/2002 | CN1376661A Indandione compounds and its preparing process and application |
10/30/2002 | CN1376659A Process for preparing chiral desubstituted carbinol with high selectivity |
10/30/2002 | CA2407813A1 Method for producing cyclic lactams |
10/29/2002 | US6472537 Polyamides for binding in the minor groove of double stranded DNA |
10/29/2002 | US6472529 Viricides |
10/29/2002 | US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates |
10/29/2002 | US6472466 Reaction product of a multi-functional aldehyde with an amine having an electron withdrawing group at the alpha position; imine-ester undergoes cycloaddition curing with unsaturated acid of an unsaturated polyester to form an enamel |
10/29/2002 | US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor |
10/29/2002 | US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents |
10/29/2002 | US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
10/29/2002 | US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |